US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

AEON Biopharma

1.11

-0.0600-5.13%

Post-market: 1.130.0200+1.80%17:39 EDT

Volume:69.03K

Turnover:79.07K

Market Cap:13.44M

PE:0.23

High:1.22

Open:1.22

Low:1.05

Close:1.17

52wk High:1.45

52wk Low:0.3750

Shares:12.11M

Float Shares:8.66M

Volume Ratio:0.97

T/O Rate:0.80%

Dividend:- -

Dividend Rate:- -

EPS(TTM):4.87

EPS(LYR):72.93

ROE:--

ROA:-165.52%

PB:-0.68

PE(LYR):0.02

Loading ...

Overview Company News Filings

AEON Biopharma Files Initial Beneficial Ownership Statement Naming Daewoong Co., Ltd

AEON Fantasy Swings Back to Profit with Strong Nine-Month Earnings and Confirms Full-Year Outlook

AEON Biopharma Holds Meeting With FDA for Botox Biosimilar

AEON Biopharma Advances Biosimilar Program and Debt Reduction

AEON Biopharma Inc. Held Shareholder Meeting

AEON Biopharma Reports BPD Type 2a Meeting with FDA and Shareholder Approval of the November Transactions

Mizuho Securities Reaffirms Their Hold Rating on AEON Co (AONNF)

AEON Fantasy Posts Double-Digit Domestic Sales Growth in December Amid Mixed Overseas Trends

AEON Finalizes Quarterly Audit Review and Updates TSURUHA Deal Disclosure

AEON Biopharma Unveils Strategy to Launch BOTOX Biosimilar ABP-450 for Full Therapeutic Indications

AEON Financial Service's Attributable Profit Rises 5% in Fiscal Nine Months

MT Newswires Live

AEON CREDIT (00900) Reports Q3 Earnings with HK$353 Million Profit, Up 28.11% YoY

AEON and United Super Markets to Merge Supermarket Subsidiaries; Creating Tokyo Area Retail Giant

MT Newswires Live

AEON Biopharma Grants 392,158 RSUs to New Employees Under 2025 Inducement Plan

AEON Biopharma Reports Inducement Grants Under NYSE American LLC Company Guide Section 711

AEON Biopharma Inc. Announces Date for Upcoming Special Meeting of Stockholders

AEON Credit Service (M)'s Profit Soars in Fiscal Q3

MT Newswires Live

BRIEF-Aeon Biopharma Announces Execution Of Exchange Agreement With Daewoong

AEON Biopharma Strikes Debt-for-Equity Deal With Daewoong

AEON Biopharma Announces Execution of Exchange Agreement With Daewoong

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/AEON/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"AEON","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"AEON\",,,,,undefined,":{"symbol":"AEON","market":"US","secType":"STK","nameCN":"AEON Biopharma","latestPrice":1.11,"timestamp":1773432000000,"preClose":1.17,"halted":0,"volume":69025,"hourTrading":{"tag":"盘后","latestPrice":1.13,"preClose":1.11,"latestTime":"17:39 EDT","volume":1846,"amount":2037.305,"timestamp":1773437940584,"change":0.02,"changeRate":0.018018,"amplitude":0.054054},"delay":0,"changeRate":-0.05128205128205114,"floatShares":8658500,"shares":12105900,"eps":4.87,"marketStatus":"Market Closed","change":-0.06,"latestTime":"03-13 16:00:00 EDT","open":1.22,"high":1.22,"low":1.05,"amount":79070.2565675,"amplitude":0.145299,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":4.87,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1773648000000},"marketStatusCode":7,"adr":0,"exchange":"AMEX","adjPreClose":1.17,"preHourTrading":{"tag":"盘前","latestPrice":1.17,"preClose":1.17,"latestTime":"09:11 EDT","volume":186,"amount":213.8099946,"timestamp":1773407471298,"change":0,"changeRate":0,"amplitude":0.025641},"postHourTrading":{"tag":"盘后","latestPrice":1.13,"preClose":1.11,"latestTime":"17:39 EDT","volume":1846,"amount":2037.305,"timestamp":1773437940584,"change":0.02,"changeRate":0.018018,"amplitude":0.054054},"volumeRatio":0.9722920370905908},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"AEON\",,,,,undefined,":{"symbol":"AEON","floatShares":8658500,"roa":"-165.52%","roe":"--","lyrEps":72.93,"volumeRatio":0.9722920370905908,"shares":12105900,"dividePrice":0,"high":1.22,"amplitude":0.145299,"preClose":1.17,"low":1.05,"week52Low":0.375,"pbRate":"-0.68","week52High":1.45,"institutionHeld":0,"latestPrice":1.11,"eps":4.87,"divideRate":0,"volume":69025,"delay":0,"ttmEps":4.87,"open":1.22,"prevYearClose":1.1,"prevWeekClose":1.06,"prevMonthClose":1.12,"prevQuarterClose":1.1,"fiveDayClose":1.06,"twentyDayClose":0.9486,"sixtyDayClose":0.864},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/AEON\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-02-26","symbol":"AEON","defaultRemindTime":1740580200000,"type":"split","dateTimestamp":1740546000000,"forFactor":72,"toFactor":1,"ratio":72}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"AEON\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"AEON\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":2,"updateTime":1763179200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/AEON\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"AEON","date":"2026-03-12","current":0.227926,"percent":0.006309,"low":-10627.284333,"twenty":-9.623566,"median":-2.276273,"eighty":0.114934,"high":2.629651,"avg":-727.207115,"sd":2160.701446,"marketCap":29351547},"quantilePoints":[{"date":"2023-07-28","current":-3.37691,"twenty":-21.448776,"median":-11.461912,"eighty":-3.316366,"marketCap":177476894},{"date":"2023-08-04","current":-5.443476,"twenty":-11.148476,"median":-5.443476,"eighty":-3.386305,"marketCap":286087324},{"date":"2023-08-11","current":-5.188976,"twenty":-5.600418,"median":-5.478823,"eighty":-4.466171,"marketCap":272711813},{"date":"2023-08-18","current":-3.068141,"twenty":-5.560829,"median":-5.188976,"eighty":-3.316366,"marketCap":161249219},{"date":"2023-08-25","current":-2.01912,"twenty":-5.541035,"median":-4.414871,"eighty":-2.956443,"marketCap":157533799},{"date":"2023-09-01","current":-2.542949,"twenty":-5.522654,"median":-3.37691,"eighty":-2.403896,"marketCap":198403417},{"date":"2023-09-08","current":-2.342942,"twenty":-5.485892,"median":-3.110558,"eighty":-2.227699,"marketCap":182798654},{"date":"2023-09-15","current":-2.652477,"twenty":-5.347332,"median":-2.95503,"eighty":-2.273416,"marketCap":206948882},{"date":"2023-09-22","current":-2.914391,"twenty":-5.197459,"median":-2.95725,"eighty":-2.302941,"marketCap":227383691},{"date":"2023-09-29","current":-2.838198,"twenty":-5.186148,"median":-2.9407,"eighty":-2.401992,"marketCap":221439020},{"date":"2023-10-06","current":-3.00487,"twenty":-5.094245,"median":-2.923915,"eighty":-2.50009,"marketCap":234442989},{"date":"2023-10-13","current":-2.904867,"twenty":-4.524447,"median":-2.928677,"eighty":-2.525805,"marketCap":226640607},{"date":"2023-10-20","current":-2.795339,"twenty":-3.677221,"median":-2.928677,"eighty":-2.550568,"marketCap":218095142},{"date":"2023-10-27","current":-2.242938,"twenty":-3.487452,"median":-2.923915,"eighty":-2.537234,"marketCap":174996272},{"date":"2023-11-03","current":-2.404849,"twenty":-3.380042,"median":-2.905206,"eighty":-2.454375,"marketCap":187628699},{"date":"2023-11-10","current":-2.100076,"twenty":-3.255821,"median":-2.857246,"eighty":-2.276273,"marketCap":163850013},{"date":"2023-11-17","current":-6.097255,"twenty":-3.380042,"median":-2.847722,"eighty":-2.265796,"marketCap":175021716},{"date":"2023-11-24","current":-6.653905,"twenty":-5.050414,"median":-2.883437,"eighty":-2.274368,"marketCap":191000344},{"date":"2023-12-01","current":-7.365899,"twenty":-5.471754,"median":-2.914391,"eighty":-2.276273,"marketCap":211438124},{"date":"2023-12-08","current":-7.870767,"twenty":-5.600418,"median":-2.931058,"eighty":-2.307702,"marketCap":225930368},{"date":"2023-12-15","current":-7.314117,"twenty":-6.190462,"median":-2.95725,"eighty":-2.337227,"marketCap":209951740},{"date":"2023-12-22","current":-7.314117,"twenty":-6.653905,"median":-2.962099,"eighty":-2.367705,"marketCap":209951740},{"date":"2023-12-29","current":-9.087629,"twenty":-6.767824,"median":-2.969199,"eighty":-2.380086,"marketCap":260860392},{"date":"2024-01-05","current":-10.019694,"twenty":-7.14065,"median":-3.000108,"eighty":-2.41723,"marketCap":287615304},{"date":"2024-01-12","current":-9.126465,"twenty":-7.314117,"median":-3.048411,"eighty":-2.471518,"marketCap":261975180},{"date":"2024-01-19","current":-9.255918,"twenty":-7.573024,"median":-3.07392,"eighty":-2.490566,"marketCap":265691140},{"date":"2024-01-26","current":-10.744633,"twenty":-7.831931,"median":-3.110558,"eighty":-2.514376,"marketCap":308424680},{"date":"2024-02-02","current":-9.242973,"twenty":-8.414471,"median":-3.301229,"eighty":-2.514376,"marketCap":265319544},{"date":"2024-02-09","current":-11.650806,"twenty":-9.126465,"median":-3.866989,"eighty":-2.542949,"marketCap":334436400},{"date":"2024-02-16","current":-12.699379,"twenty":-9.255918,"median":-5.185441,"eighty":-2.561997,"marketCap":364535676},{"date":"2024-02-23","current":-13.527881,"twenty":-9.341358,"median":-5.323296,"eighty":-2.565807,"marketCap":388317820},{"date":"2024-03-01","current":-15.404955,"twenty":-9.623566,"median":-5.535379,"eighty":-2.635333,"marketCap":442199240},{"date":"2024-03-08","current":-15.806261,"twenty":-10.537507,"median":-5.606073,"eighty":-2.663906,"marketCap":453718716},{"date":"2024-03-15","current":-18.770744,"twenty":-11.073444,"median":-6.08431,"eighty":-2.70105,"marketCap":538814200},{"date":"2024-03-22","current":-14.110421,"twenty":-11.650806,"median":-6.369108,"eighty":-2.709622,"marketCap":405039640},{"date":"2024-03-28","current":-15.767425,"twenty":-12.002919,"median":-6.653905,"eighty":-2.718194,"marketCap":452603928},{"date":"2024-04-05","current":-8.500224,"twenty":-11.974754,"median":-7.119937,"eighty":-2.73248,"marketCap":311380189},{"date":"2024-04-12","current":-8.77875,"twenty":-11.932361,"median":-7.229973,"eighty":-2.761052,"marketCap":321583181},{"date":"2024-04-19","current":-6.746537,"twenty":-11.754369,"median":-7.197609,"eighty":-2.78772,"marketCap":247139131},{"date":"2024-04-26","current":-4.384217,"twenty":-11.650806,"median":-7.113764,"eighty":-2.818197,"marketCap":160602646},{"date":"2024-05-03","current":-3.557269,"twenty":-11.635272,"median":-6.938703,"eighty":-2.836293,"marketCap":130309865},{"date":"2024-05-10","current":-1.75746,"twenty":-11.609381,"median":-6.653905,"eighty":-2.73248,"marketCap":64379278},{"date":"2024-05-17","current":-0.424594,"twenty":-11.389311,"median":-6.330272,"eighty":-2.661049,"marketCap":58174047},{"date":"2024-05-24","current":-0.478376,"twenty":-11.117458,"median":-5.909548,"eighty":-2.53152,"marketCap":65542759},{"date":"2024-05-31","current":-0.40761,"twenty":-11.024252,"median":-5.606073,"eighty":-2.47628,"marketCap":55847085},{"date":"2024-06-07","current":-0.468287,"twenty":-10.933635,"median":-5.535379,"eighty":-2.297226,"marketCap":64160470},{"date":"2024-06-14","current":-0.388336,"twenty":-10.796414,"median":-5.443476,"eighty":-2.248653,"marketCap":53206243},{"date":"2024-06-21","current":-0.362637,"twenty":-10.744633,"median":-5.203115,"eighty":-2.200079,"marketCap":49685242},{"date":"2024-06-28","current":-0.302673,"twenty":-10.64107,"median":-5.188976,"eighty":-2.19246,"marketCap":41469572},{"date":"2024-07-05","current":-0.274276,"twenty":-10.431356,"median":-4.962753,"eighty":-2.107695,"marketCap":37578865},{"date":"2024-07-12","current":-0.302673,"twenty":-10.175038,"median":-4.621481,"eighty":-1.959118,"marketCap":41469572},{"date":"2024-07-15","current":-0.399757,"twenty":-10.136202,"median":-4.435796,"eighty":-1.957213,"marketCap":54771133},{"date":"2024-08-02","current":-0.328372,"twenty":-10.097366,"median":-4.410006,"eighty":-1.94007,"marketCap":44990573},{"date":"2024-08-09","current":-0.283199,"twenty":-9.794445,"median":-4.116006,"eighty":-1.791339,"marketCap":38801435},{"date":"2024-08-16","current":0.976891,"twenty":-9.628744,"median":-3.823294,"eighty":-1.725699,"marketCap":41498349},{"date":"2024-08-23","current":0.902462,"twenty":-9.587319,"median":-3.392568,"eighty":-0.494794,"marketCap":38336570},{"date":"2024-08-30","current":0.882459,"twenty":-9.465633,"median":-3.198546,"eighty":-0.467793,"marketCap":37486842},{"date":"2024-09-06","current":0.760487,"twenty":-9.387961,"median":-3.102954,"eighty":-0.447239,"marketCap":32305477},{"date":"2024-09-13","current":0.689406,"twenty":-9.356893,"median":-3.071539,"eighty":-0.436887,"marketCap":29285978},{"date":"2024-09-20","current":0.622419,"twenty":-9.328413,"median":-3.016776,"eighty":-0.426081,"marketCap":26440377},{"date":"2024-09-27","current":0.798539,"twenty":-9.299933,"median":-2.976298,"eighty":-0.398044,"marketCap":33921936},{"date":"2024-10-04","current":1.032714,"twenty":-9.263686,"median":-2.95725,"eighty":-0.370632,"marketCap":43869684},{"date":"2024-10-11","current":1.02341,"twenty":-9.25074,"median":-2.933439,"eighty":-0.302673,"marketCap":43474461},{"date":"2024-10-18","current":1.004803,"twenty":-9.222261,"median":-2.919153,"eighty":-0.296962,"marketCap":42684017},{"date":"2024-10-25","current":-0.131948,"twenty":-9.191192,"median":-2.904867,"eighty":-0.28642,"marketCap":40312682},{"date":"2024-10-31","current":-0.119232,"twenty":-9.178247,"median":-2.857246,"eighty":-0.27525,"marketCap":36427646},{"date":"2024-11-08","current":-0.104122,"twenty":-9.123876,"median":-2.835817,"eighty":-0.130913,"marketCap":31811449},{"date":"2024-11-15","current":-0.079143,"twenty":-9.108342,"median":-2.776291,"eighty":-0.126778,"marketCap":24179705},{"date":"2024-11-22","current":-0.072313,"twenty":-9.072095,"median":-2.716765,"eighty":-0.11348,"marketCap":22092931},{"date":"2024-11-29","current":1.589186,"twenty":-9.009957,"median":-2.688192,"eighty":-0.104122,"marketCap":21740059},{"date":"2024-12-06","current":1.876402,"twenty":-8.820014,"median":-2.566759,"eighty":-0.079828,"marketCap":25669179},{"date":"2024-12-13","current":2.074502,"twenty":-8.77875,"median":-2.528663,"eighty":-0.072908,"marketCap":28379192},{"date":"2024-12-20","current":1.897731,"twenty":-8.77875,"median":-2.490566,"eighty":-0.068574,"marketCap":25960965},{"date":"2024-12-27","current":1.753101,"twenty":-8.687971,"median":-2.404849,"eighty":0.64112,"marketCap":23982415},{"date":"2025-01-03","current":1.606424,"twenty":-8.566245,"median":-2.328655,"eighty":0.670743,"marketCap":21975887},{"date":"2025-01-10","current":0.555441,"twenty":-8.465923,"median":-2.276273,"eighty":0.673831,"marketCap":7598428},{"date":"2025-01-17","current":0.499341,"twenty":-8.386877,"median":-2.242938,"eighty":0.661104,"marketCap":6830991},{"date":"2025-01-24","current":0.373995,"twenty":-8.306286,"median":-2.214365,"eighty":0.653875,"marketCap":5116248},{"date":"2025-01-31","current":0.355003,"twenty":-8.119633,"median":-2.190555,"eighty":0.644804,"marketCap":4856439},{"date":"2025-02-07","current":0.409057,"twenty":-7.992936,"median":-2.119124,"eighty":0.64112,"marketCap":5595897},{"date":"2025-02-14","current":0.759955,"twenty":-7.945195,"median":-1.990548,"eighty":0.662835,"marketCap":10396190},{"date":"2025-02-21","current":0.627255,"twenty":-7.870767,"median":-1.957213,"eighty":0.672268,"marketCap":8580855},{"date":"2025-02-28","current":0.069013,"twenty":-7.844876,"median":-1.894137,"eighty":0.672268,"marketCap":944098},{"date":"2025-03-07","current":0.057646,"twenty":-7.840012,"median":-1.799809,"eighty":0.664565,"marketCap":788599},{"date":"2025-03-14","current":0.048796,"twenty":-7.831931,"median":-1.757333,"eighty":0.655913,"marketCap":667533},{"date":"2025-03-21","current":0.058864,"twenty":-7.818986,"median":-1.725699,"eighty":0.645725,"marketCap":805260},{"date":"2025-03-28","current":0.160481,"twenty":-7.78015,"median":-0.533573,"eighty":0.64112,"marketCap":6740993},{"date":"2025-04-04","current":0.133274,"twenty":-7.664643,"median":-0.479709,"eighty":0.64112,"marketCap":5598184},{"date":"2025-04-11","current":0.102632,"twenty":-7.624806,"median":-0.46767,"eighty":0.637193,"marketCap":4311075},{"date":"2025-04-17","current":0.100275,"twenty":-7.58338,"median":-0.455731,"eighty":0.629243,"marketCap":4212067},{"date":"2025-04-25","current":0.115346,"twenty":-7.407324,"median":-0.445444,"eighty":0.624131,"marketCap":4845088},{"date":"2025-05-02","current":0.109578,"twenty":-7.340008,"median":-0.437837,"eighty":0.622605,"marketCap":4602834},{"date":"2025-05-09","current":0.114844,"twenty":-7.326085,"median":-0.431167,"eighty":0.615352,"marketCap":4824023},{"date":"2025-05-16","current":0.032963,"twenty":-7.316138,"median":-0.424594,"eighty":0.56707,"marketCap":5574676},{"date":"2025-05-23","current":0.0367,"twenty":-7.314117,"median":-0.399757,"eighty":0.544922,"marketCap":6206646},{"date":"2025-05-30","current":0.04027,"twenty":-7.283048,"median":-0.390626,"eighty":0.516521,"marketCap":6810353},{"date":"2025-06-06","current":0.048786,"twenty":-7.2235,"median":-0.372631,"eighty":0.469714,"marketCap":8250656},{"date":"2025-06-13","current":0.059623,"twenty":-7.16654,"median":-0.314095,"eighty":0.427172,"marketCap":10083256},{"date":"2025-06-20","current":0.051474,"twenty":-7.135472,"median":-0.302673,"eighty":0.41081,"marketCap":8705132},{"date":"2025-06-27","current":0.050992,"twenty":-7.114998,"median":-0.29839,"eighty":0.40707,"marketCap":8623733},{"date":"2025-07-03","current":0.055993,"twenty":-7.086958,"median":-0.296962,"eighty":0.40219,"marketCap":9469375},{"date":"2025-07-11","current":0.05749,"twenty":-6.991286,"median":-0.291252,"eighty":0.394592,"marketCap":9722615},{"date":"2025-07-18","current":0.052075,"twenty":-6.90027,"median":-0.280145,"eighty":0.391817,"marketCap":8806880},{"date":"2025-07-25","current":0.054281,"twenty":-6.728011,"median":-0.274276,"eighty":0.38054,"marketCap":9179958},{"date":"2025-08-01","current":0.048619,"twenty":-6.653905,"median":-0.131301,"eighty":0.379429,"marketCap":8222393},{"date":"2025-08-08","current":0.047683,"twenty":-6.604713,"median":-0.129361,"eighty":0.377735,"marketCap":8064118},{"date":"2025-08-15","current":-5.551438,"twenty":-6.39241,"median":-0.129361,"eighty":0.377209,"marketCap":9082153},{"date":"2025-08-22","current":-4.910888,"twenty":-6.283669,"median":-0.131948,"eighty":0.375631,"marketCap":8034212},{"date":"2025-08-29","current":-5.53578,"twenty":-6.094666,"median":-0.274276,"eighty":0.373411,"marketCap":9056536},{"date":"2025-09-05","current":-5.463896,"twenty":-6.08431,"median":-0.280145,"eighty":0.371073,"marketCap":8938934},{"date":"2025-09-12","current":-5.508735,"twenty":-5.764955,"median":-0.291252,"eighty":0.366982,"marketCap":9012290},{"date":"2025-09-19","current":-5.409094,"twenty":-5.734786,"median":-0.296962,"eighty":0.365814,"marketCap":8849277},{"date":"2025-09-26","current":-5.542186,"twenty":-5.634351,"median":-0.299818,"eighty":0.364061,"marketCap":9067016},{"date":"2025-10-03","current":-5.8041,"twenty":-5.764955,"median":-0.302673,"eighty":0.355003,"marketCap":9495507},{"date":"2025-10-10","current":-7.330745,"twenty":-5.992706,"median":-0.328372,"eighty":0.352081,"marketCap":11993099},{"date":"2025-10-17","current":-9.96412,"twenty":-6.330272,"median":-0.385481,"eighty":0.35062,"marketCap":16301300},{"date":"2025-10-24","current":-6.468137,"twenty":-6.653905,"median":-0.396902,"eighty":0.320233,"marketCap":10581872},{"date":"2025-10-31","current":-6.006941,"twenty":-6.653905,"median":-0.416102,"eighty":0.175501,"marketCap":9827355},{"date":"2025-11-07","current":-6.930757,"twenty":-6.65532,"median":-0.428311,"eighty":0.160481,"marketCap":11338718},{"date":"2025-11-14","current":-6.690194,"twenty":-6.65532,"median":-0.432127,"eighty":0.148846,"marketCap":10945158},{"date":"2025-11-21","current":-3183.022667,"twenty":-6.690194,"median":-0.442588,"eighty":0.148698,"marketCap":9549068},{"date":"2025-11-28","current":-3287.428667,"twenty":-6.932346,"median":-0.447239,"eighty":0.145988,"marketCap":9862286},{"date":"2025-12-05","current":-2953.692333,"twenty":-7.125115,"median":-0.465638,"eighty":0.137567,"marketCap":8861077},{"date":"2025-12-12","current":-2999.073,"twenty":-7.260126,"median":-0.478376,"eighty":0.134127,"marketCap":8997219},{"date":"2025-12-19","current":-3985.610333,"twenty":-7.325527,"median":-0.492529,"eighty":0.133369,"marketCap":11956831},{"date":"2025-12-26","current":-4143.456333,"twenty":-7.448749,"median":-1.123323,"eighty":0.128866,"marketCap":12430369},{"date":"2026-01-02","current":-4340.763667,"twenty":-7.648708,"median":-1.725699,"eighty":0.125837,"marketCap":13022291},{"date":"2026-01-09","current":-4301.302333,"twenty":-7.828951,"median":-1.75746,"eighty":0.125361,"marketCap":12903907},{"date":"2026-01-16","current":-4538.071333,"twenty":-7.860411,"median":-1.815689,"eighty":0.124458,"marketCap":13614214},{"date":"2026-01-23","current":-4616.994,"twenty":-8.034018,"median":-1.894137,"eighty":0.123771,"marketCap":13850982},{"date":"2026-01-30","current":-9529.631667,"twenty":-8.312923,"median":-1.957213,"eighty":0.122763,"marketCap":28588895},{"date":"2026-02-06","current":-8568.660333,"twenty":-8.632266,"median":-2.004834,"eighty":0.120009,"marketCap":25705981},{"date":"2026-02-13","current":-8001.248333,"twenty":-8.971968,"median":-2.138172,"eighty":0.118335,"marketCap":24003745},{"date":"2026-02-20","current":-10121.223,"twenty":-9.126465,"median":-2.190555,"eighty":0.11685,"marketCap":30363669},{"date":"2026-02-27","current":-9193.444333,"twenty":-9.255918,"median":-2.214365,"eighty":0.115346,"marketCap":27580333},{"date":"2026-03-06","current":-8687.383,"twenty":-9.372427,"median":-2.242938,"eighty":0.115292,"marketCap":26062149},{"date":"2026-03-12","current":-9783.849,"twenty":-9.623566,"median":-2.276273,"eighty":0.114934,"marketCap":29351547}],"updateTime":1773465519666},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"AEON\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2607771069","title":"AEON Biopharma Files Initial Beneficial Ownership Statement Naming Daewoong Co., Ltd","url":"https://stock-news.laohu8.com/highlight/detail?id=2607771069","media":"Reuters","labels":["insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607771069?lang=en_us&edition=fundamental","pubTime":"2026-01-30 10:25","pubTimestamp":1769739949,"startTime":"0","endTime":"0","summary":"AEON Biopharma Inc. has filed an initial statement of beneficial ownership, naming Daewoong Co., Ltd. as the beneficial owner. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. AEON Biopharma Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on January 29, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260130:nNDLbfPtxp:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"AEON Biopharma Files Initial Beneficial Ownership Statement Naming Daewoong Co., Ltd","news_tag":"insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","AEON"],"gpt_icon":0},{"id":"2605445444","title":"AEON Fantasy Swings Back to Profit with Strong Nine-Month Earnings and Confirms Full-Year Outlook","url":"https://stock-news.laohu8.com/highlight/detail?id=2605445444","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605445444?lang=en_us&edition=fundamental","pubTime":"2026-01-22 13:22","pubTimestamp":1769059349,"startTime":"0","endTime":"0","summary":"The latest update is out from AEON Fantasy Co., Ltd. ( ($JP:4343) ). AEON Fantasy Co., Ltd. reported consolidated net sales of ¥68.17 billion for t...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/aeon-fantasy-swings-back-to-profit-with-strong-nine-month-earnings-and-confirms-full-year-outlook?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/aeon-fantasy-swings-back-to-profit-with-strong-nine-month-earnings-and-confirms-full-year-outlook?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["AEON"],"gpt_icon":0},{"id":"2605435901","title":"AEON Biopharma Holds Meeting With FDA for Botox Biosimilar","url":"https://stock-news.laohu8.com/highlight/detail?id=2605435901","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605435901?lang=en_us&edition=fundamental","pubTime":"2026-01-22 05:46","pubTimestamp":1769031960,"startTime":"0","endTime":"0","summary":"AEON Biopharma met with the Food and Drug Administration regarding its biosimilar for Botox and plans to comment on the meeting after receiving official minutes.The biopharmaceutical company said Wednesday it held a scheduled BPD Type 2a meeting, which is meant to focus specifically on a narrow set of issues. The meeting aimed to review AEON's analytical development plan and initial data supporting biosimilarity, AEON said in November.The company expects the minutes to inform its next steps for the development of ABP-450, Chief Executive Rob Bancroft said. It is seeking accelerated and full-label U.S. market entry for ABP-450.\"The completion of our BPD Type 2a meeting with FDA represents an important procedural milestone,\" Bancroft said.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AEON","BK4139"],"gpt_icon":0},{"id":"2605435637","title":"AEON Biopharma Advances Biosimilar Program and Debt Reduction","url":"https://stock-news.laohu8.com/highlight/detail?id=2605435637","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605435637?lang=en_us&edition=fundamental","pubTime":"2026-01-22 05:30","pubTimestamp":1769031052,"startTime":"0","endTime":"0","summary":"AEON Biopharma ( ($AEON) ) just unveiled an announcement. On January 21, 2026, AEON Biopharma reported that it had held its scheduled Biosimilar Pr...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/aeon-biopharma-advances-biosimilar-program-and-debt-reduction?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/aeon-biopharma-advances-biosimilar-program-and-debt-reduction?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","AEON"],"gpt_icon":0},{"id":"2605743805","title":"AEON Biopharma Inc. Held Shareholder Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2605743805","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605743805?lang=en_us&edition=fundamental","pubTime":"2026-01-22 05:05","pubTimestamp":1769029537,"startTime":"0","endTime":"0","summary":"AEON Biopharma Inc. held a special meeting on January 21, 2026. Shareholders approved the proposals required to complete the transactions announced in November, including the remaining issuances related to the company's private investment in public equity  financing and the exchange of convertible notes held by Daewoong Pharmaceutical Co., Ltd. The Daewoong note exchange closed following shareholder approval, substantially reducing outstanding debt and simplifying the capital structure. The company expects to proceed with the second closing of the PIPE financing on or around January 27, 2026, subject to customary closing conditions.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. AEON Biopharma Inc. published the original content used t","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260121:nNDL9kS3v1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","IE00BGHQF748.EUR","IE00BKPKM429.USD","LU2210149790.SGD","SG9999014021.USD","BK4112","IE00B64PRP62.GBP","LU2095319765.USD","SG9999014013.SGD","LU2210150020.SGD","LU0314104364.USD","BK4139","BK4588","NDAQ","SG9999014005.SGD","AEON","SG9999014039.USD","IE00B3QW5Z07.USD"],"gpt_icon":0},{"id":"2605543807","title":"AEON Biopharma Reports BPD Type 2a Meeting with FDA and Shareholder Approval of the November Transactions","url":"https://stock-news.laohu8.com/highlight/detail?id=2605543807","media":"GlobeNewswire","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605543807?lang=en_us&edition=fundamental","pubTime":"2026-01-22 05:05","pubTimestamp":1769029500,"startTime":"0","endTime":"0","summary":"-AEON confirmed that earlier today it held its BPD Type 2a Meeting with the FDA, in line with prior guidance, and is now awaiting official meeting minutes - - Separately, AEON shareholders today voted","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/01/21/3223230/0/en/AEON-Biopharma-Reports-BPD-Type-2a-Meeting-with-FDA-and-Shareholder-Approval-of-the-November-Transactions.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","AEON"],"gpt_icon":0},{"id":"2604134222","title":"Mizuho Securities Reaffirms Their Hold Rating on AEON Co (AONNF)","url":"https://stock-news.laohu8.com/highlight/detail?id=2604134222","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2604134222?lang=en_us&edition=fundamental","pubTime":"2026-01-19 23:26","pubTimestamp":1768836395,"startTime":"0","endTime":"0","summary":"In a report released today, from Mizuho Securities maintained a Hold rating on AEON Co, with a price target of Yen2,200.00. In a report released on...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/mizuho-securities-reaffirms-their-hold-rating-on-aeon-co-aonnf-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/mizuho-securities-reaffirms-their-hold-rating-on-aeon-co-aonnf-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["AEON","MFG","AONNF"],"gpt_icon":0},{"id":"2603767716","title":"AEON Fantasy Posts Double-Digit Domestic Sales Growth in December Amid Mixed Overseas Trends","url":"https://stock-news.laohu8.com/highlight/detail?id=2603767716","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603767716?lang=en_us&edition=fundamental","pubTime":"2026-01-15 14:54","pubTimestamp":1768460079,"startTime":"0","endTime":"0","summary":"AEON Fantasy Co., Ltd. ( ($JP:4343) ) has provided an update. AEON Fantasy Co., Ltd. reported that net sales in Japan for December 2025 reached JPY...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/aeon-fantasy-posts-double-digit-domestic-sales-growth-in-december-amid-mixed-overseas-trends?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/aeon-fantasy-posts-double-digit-domestic-sales-growth-in-december-amid-mixed-overseas-trends?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["AEON"],"gpt_icon":0},{"id":"2603866056","title":"AEON Finalizes Quarterly Audit Review and Updates TSURUHA Deal Disclosure","url":"https://stock-news.laohu8.com/highlight/detail?id=2603866056","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603866056?lang=en_us&edition=fundamental","pubTime":"2026-01-14 15:15","pubTimestamp":1768374958,"startTime":"0","endTime":"0","summary":"AEON Co ( ($JP:8267) ) just unveiled an announcement. AEON Co. has announced that its independent auditor has completed the quarterly review of its...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/aeon-finalizes-quarterly-audit-review-and-updates-tsuruha-deal-disclosure?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/aeon-finalizes-quarterly-audit-review-and-updates-tsuruha-deal-disclosure?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["AEON","BK4139"],"gpt_icon":0},{"id":"2602545719","title":"AEON Biopharma Unveils Strategy to Launch BOTOX Biosimilar ABP-450 for Full Therapeutic Indications","url":"https://stock-news.laohu8.com/highlight/detail?id=2602545719","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602545719?lang=en_us&edition=fundamental","pubTime":"2026-01-12 22:23","pubTimestamp":1768227801,"startTime":"0","endTime":"0","summary":"AEON Biopharma Inc. has released a corporate presentation outlining its strategy to introduce ABP-450, a biosimilar to BOTOX, into the U.S. therapeutic neurotoxin market. The company aims to achieve clinical equivalence with BOTOX and pursue all 12 therapeutic indications currently held by the brand. ABP-450 is based on a globally validated manufacturing platform, already approved in over 69 countries and FDA-approved for aesthetics under the Jeuveau brand. AEON Biopharma positions ABP-450 as a clinically indistinguishable alternative, seeking to enable confident switching by providers, achieve payer coverage parity, and offer a competitive option to address rising neurotoxin costs. The U.S. therapeutic neurotoxin market is projected to exceed $5 billion by 2030, with BOTOX currently maintaining over 65% market share. You can access the full presentation through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. Whil","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260112:nNDL12hc4z:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AEON","BK4139"],"gpt_icon":0},{"id":"2601335455","title":"AEON Financial Service's Attributable Profit Rises 5% in Fiscal Nine Months","url":"https://stock-news.laohu8.com/highlight/detail?id=2601335455","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601335455?lang=en_us&edition=fundamental","pubTime":"2026-01-08 16:51","pubTimestamp":1767862263,"startTime":"0","endTime":"0","summary":"AEON Financial Service's  profit attributable to owners of the parent rose 5% to 14.4 billion yen for the fiscal nine months from 13.8 billion yen a year earlier.The credit card company's net income per share rose to 66.92 yen from 63.75 yen a year ago, according to a Tokyo bourse filing on Thursday.Operating income jumped 8.4% to 421.6 billion yen in the nine months ended Nov. 30, 2025 from 388.8 billion yen in the year-ago period.For the full fiscal year ending Feb. 28, 2026, the company expects attributable profit of 21.0 billion yen, net income per share of 97.28 yen, and operating income of 570.0 billion yen.It plans to pay a year-end dividend of 28.00 yen per share for the current fiscal year.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","AEON"],"gpt_icon":0},{"id":"1170004494","title":"AEON CREDIT (00900) Reports Q3 Earnings with HK$353 Million Profit, Up 28.11% YoY","url":"https://stock-news.laohu8.com/highlight/detail?id=1170004494","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1170004494?lang=en_us&edition=fundamental","pubTime":"2025-12-23 18:44","pubTimestamp":1766486651,"startTime":"0","endTime":"0","summary":"AEON CREDIT (00900) announced its financial results for the nine months ended November 30, 2025. The group recorded revenue of HK$1.358 billion, a 4.1% year-on-year increase. Net profit rose 28.11% YoY to HK$353 million, with basic earnings per share at HK84.22 cents.","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1188","00900","AEON","BK4139"],"gpt_icon":0},{"id":"2593970489","title":"AEON and United Super Markets to Merge Supermarket Subsidiaries; Creating Tokyo Area Retail Giant","url":"https://stock-news.laohu8.com/highlight/detail?id=2593970489","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593970489?lang=en_us&edition=fundamental","pubTime":"2025-12-22 18:47","pubTimestamp":1766400479,"startTime":"0","endTime":"0","summary":"Aeon  and United Super Markets  are consolidating their supermarket operations in the Tokyo metropolitan area to create a dominant retail group with over 1 trillion yen in sales.The deal involves United Super Markets' subsidiary Maxvalu Kanto absorbing Aeon Market and taking over the Kanto region supermarket business of The Daiei, according to its Tokyo bourse filing on Monday.Following these two transactions -- an absorption-type merger and an absorption-type company split -- United Super Markets will acquire 100% of Maxvalu Kanto's shares from Aeon through a share exchange, issuing approximately 11.5 million new United Super Markets shares.The integration, scheduled to take effect on March 1, 2026, will see more than 1,000 stores by combining the networks, customer bases, and management resources of the involved companies.To ensure fairness in this transaction between companies under the common control of Aeon, United Super Markets established a special committee of independent direc","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["UBCP","BK4139","BK4211","AEON"],"gpt_icon":0},{"id":"2592113300","title":"AEON Biopharma Grants 392,158 RSUs to New Employees Under 2025 Inducement Plan","url":"https://stock-news.laohu8.com/highlight/detail?id=2592113300","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592113300?lang=en_us&edition=fundamental","pubTime":"2025-12-20 07:00","pubTimestamp":1766185211,"startTime":"0","endTime":"0","summary":"AEON Biopharma Inc. has granted a total of 392,158 restricted stock units  of the company's common stock to newly hired non-executive employees. The RSUs were approved under the company's 2025 Inducement Incentive Plan, with a grant date of December 11, 2025. Vesting will occur over four years, with 25% of the RSUs vesting on each annual anniversary of the vesting commencement date.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. AEON Biopharma Inc. published the original content used to generate this news brief via GlobeNewswire  on December 19, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251219:nNDL27jXxR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B3QW5Z07.USD","AEON","BK4139","IE00BKPKM429.USD","BK4112","LU0314104364.USD","SG9999014005.SGD","IE00B64PRP62.GBP","LU2095319765.USD","SG9999014013.SGD","BK4588","BK4585","SG9999014021.USD","SG9999014039.USD","NDAQ","IE00BGHQF748.EUR","LU2210150020.SGD","LU2210149790.SGD"],"gpt_icon":0},{"id":"2592711342","title":"AEON Biopharma Reports Inducement Grants Under NYSE American LLC Company Guide Section 711","url":"https://stock-news.laohu8.com/highlight/detail?id=2592711342","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592711342?lang=en_us&edition=fundamental","pubTime":"2025-12-20 07:00","pubTimestamp":1766185200,"startTime":"0","endTime":"0","summary":"IRVINE, Calif., Dec.  19, 2025  (GLOBE NEWSWIRE) -- AEON Biopharma, Inc. (“AEON” or the “Company”) (NYSE American: AEON), a biopharmaceutical company seeking accelerated and full-label U.S. market ent","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/12/19/3208775/0/en/AEON-Biopharma-Reports-Inducement-Grants-Under-NYSE-American-LLC-Company-Guide-Section-711.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4117","AEON","BK4107","BK4139","AFG","NYSE"],"gpt_icon":0},{"id":"2592971341","title":"AEON Biopharma Inc. Announces Date for Upcoming Special Meeting of Stockholders","url":"https://stock-news.laohu8.com/highlight/detail?id=2592971341","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592971341?lang=en_us&edition=fundamental","pubTime":"2025-12-20 05:02","pubTimestamp":1766178166,"startTime":"0","endTime":"0","summary":"AEON Biopharma Inc. has announced a Special Meeting of Stockholders to be held in 2026 at 5 Park Plaza, Suite 1750, Irvine, California. During the meeting, stockholders will vote on the approval of the adjournment of the Special Meeting, if necessary, to solicit additional proxies if there are not sufficient votes in favor of the PIPE Financing Proposal, the Exchange Proposal, or the Equity Plan Proposal.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. AEON Biopharma Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on December 19, 2025, and is solely responsible for the information contai","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251219:nNDL9bdCCB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AEON","BK4139"],"gpt_icon":0},{"id":"2592157939","title":"AEON Credit Service (M)'s Profit Soars in Fiscal Q3","url":"https://stock-news.laohu8.com/highlight/detail?id=2592157939","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592157939?lang=en_us&edition=fundamental","pubTime":"2025-12-19 17:17","pubTimestamp":1766135822,"startTime":"0","endTime":"0","summary":"Aeon Credit Service's  profit attributable to owners jumped 40.6% annually to 99.5 million ringgit in the fiscal third quarter ended Nov. 30 from 70.8 million ringgit a year earlier.Earnings per share went up to 0.1798 ringgit from 0.1216 ringgit a year ago, according to a Thursday Malaysian bourse filing.Revenue increased 10.7% to 622.4 million ringgit from 562 million ringgit a year ago, the Malaysian lender said.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4220","BK4103","BK4588","BK4585","AEON","BK4139"],"gpt_icon":0},{"id":"2591622826","title":"BRIEF-Aeon Biopharma Announces Execution Of Exchange Agreement With Daewoong","url":"https://stock-news.laohu8.com/highlight/detail?id=2591622826","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2591622826?lang=en_us&edition=fundamental","pubTime":"2025-12-16 05:41","pubTimestamp":1765834900,"startTime":"0","endTime":"0","summary":"BRIEF-Aeon Biopharma Announces Execution Of Exchange Agreement With DaewoongDec 15 (Reuters) - Aeon Biopharma Inc AEON.A:AEON BIOPHARMA ANNOUNCES EXECUTION OF EXCHANGE AGREEMENT WITH DAEWOONGAEON BIOP","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251215:nTUABJHX5R:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AEON","BK4139"],"gpt_icon":1},{"id":"2591621702","title":"AEON Biopharma Strikes Debt-for-Equity Deal With Daewoong","url":"https://stock-news.laohu8.com/highlight/detail?id=2591621702","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2591621702?lang=en_us&edition=fundamental","pubTime":"2025-12-16 05:05","pubTimestamp":1765832759,"startTime":"0","endTime":"0","summary":"AEON Biopharma Inc. has announced the execution of a definitive agreement with Daewoong Pharmaceutical to exchange $15 million of existing convertible notes plus accrued interest into new equity, $1.5 million of new notes due in 2030, and a cash-exercise warrant for 8 million shares of common stock. The transaction, which remains subject to shareholder approval, is expected to eliminate more than 90% of AEON's outstanding debt and strengthen the strategic relationship between the two companies. If exercised, the warrants could provide AEON with over $8 million in additional cash proceeds. The move is seen as a significant step in deleveraging AEON and supporting its strategy to develop ABP-450 as a BOTOX biosimilar.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, i","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251215:nNDL1J4ky5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BKPKM429.USD","SG9999014005.SGD","LU0314104364.USD","LU2095319765.USD","BK4112","NDAQ","IE00B3QW5Z07.USD","BK4139","LU2210150020.SGD","SG9999014021.USD","BK4585","IE00B64PRP62.GBP","AEON","SG9999014039.USD","LU2210149790.SGD","IE00BGHQF748.EUR","BK4588","SG9999014013.SGD"],"gpt_icon":0},{"id":"2591621769","title":"AEON Biopharma Announces Execution of Exchange Agreement With Daewoong","url":"https://stock-news.laohu8.com/highlight/detail?id=2591621769","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2591621769?lang=en_us&edition=fundamental","pubTime":"2025-12-16 05:05","pubTimestamp":1765832700,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251215:nTUABJHX5R:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["AEON","BK4139"],"gpt_icon":0}],"pageSize":20,"totalPage":5,"pageCount":2,"totalSize":92,"code":"91000000","status":"200"}]}}